About Needle-free Drug Delivery Technology
Needle-free drug delivery technologies are used to deliver drugs or vaccines into a patient’s body without the need for a traditional needle. The primary objectives of the development of these technologies are to eliminate NSI and its associated complications and increase patient compliance and comfort. Needle-free drug delivery systems include jet injectors, microneedles, nanopatches, and vaccine implants. The advantages of these systems over conventional syringes are expanded immunization coverage, decreased healthcare costs, and increased patient compliance. Needle-free systems expand the range of molecules that can be delivered transdermally with improved efficiency and enhance the efficacy of the drug or vaccine. Microneedles increase the efficacy of vaccines by targeting them to antigen-presenting cells mainly found just beneath the stratum corneum of the skin.
TechNavio's analysts forecast the Global Needle-free Drug Delivery Technologies market to grow at a CAGR of 13.50 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Needle-free Drug Delivery Technologies market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various needle-free drug delivery systems with active mechanisms for skin permeation such as velocity, ultrasound, iontophoresis, thermo ablation, and electrophoresis. This mode of drug delivery includes:
• Jet Injectors
• Transdermal Patches (Microneedles, Nanopatches)
TechNavio's report, the Global Needle-free Drug Delivery Technologies Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Needle-free Drug Delivery Technologies market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• 3M
• Antares Pharma
• Bioject Medical Technologies
• Glide Pharmaceutical Technologies
• PharmaJet
• Zogenix
Other Prominent Vendors
• Akra Dermojet
• Alkermes
• Alza
• Anthony Products
• Aradigm
• Bespak
• BioValve Technologies
• Crossject
• D’Antonio Consultants International
• European Pharma Group
• Evonik Industries
• Iomai
• Injex Pharma
• Lohmann Therapie-Systeme
• Medical International Technologies
• Merck
• National Medical Products
• Nemaura
• Neolabs Solutions
• Pacira Pharmaceuticals
• Penjet
• Spirit Healthcare
• Valeritas
• Zosano
• Zynerba Pharmaceuticals
Market Driver
• Increased Safety Concerns
• For a full, detailed list, view our report
Market Challenge
• Technical Issues
• For a full, detailed list, view our report
Market Trend
• Mandatory Use of Safety Injection Practices
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. NSIs - A Global Burden
06.1.1 A Temporary Solution
07. Needle-free Drug Delivery Technologies
07.1 A Sustainable Solution
07.2 Advantages
07.3 ISO 21649-2006
07.4 Latest Developments
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09. Market Segmentation by Product Type
10. Global Jet Injectors Market
10.1 Market Overview
10.1.1 Product Portfolio
10.2 Market Size and Forecast
11. Global Transdermal Patches Market
11.1 Market Overview
11.1.1 Product Portfolio
11.1.2 Market Size and Forecast
11.2 Global Microneedles Market
11.2.1 Market Overview
11.2.2 Market Size and Forecast
11.3 Global Nanopatches Market
11.3.1 Market Overview
11.3.2 Market Size and Forecast
12. Market Segmentation by Application
12.1 Global Insulin Delivery Market
12.1.1 Market Size and Forecast
12.2 Global Vaccines Market
12.2.1 Market Size and Forecast
12.3 Global Pediatric Injections Market
12.3.1 Market Size and Forecast
13. Geographical Segmentation
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2014
21.3 Other Prominent Vendors
22. Key Vendor Analysis
22.1 3M
22.1.1 Key Facts
22.1.2 Business Description
22.1.3 Business Segmentation
22.1.4 Revenue by Business Segmentation
22.1.5 Revenue Comparison 2013 and 2014
22.1.6 Sales by Geography
22.1.7 Business Strategy
22.1.8 Key Developments
22.1.9 SWOT Analysis
22.2 Antares Pharma
22.2.1 Key Facts
22.2.2 Business Description
22.2.3 Business Segmentation
22.2.4 Revenue by Business Segmentation
22.2.5 Revenue Comparison 2013 and 2014
22.2.6 Sales by Geography
22.2.7 Business Strategy
22.2.8 Key Developments
22.2.9 SWOT Analysis
22.3 Bioject Medical Technologies
22.3.1 Key Facts
22.3.2 Business Description
22.3.3 Business Segmentation
22.3.4 Revenue by Business Segmentation
22.3.5 Revenue Comparison 2013 and 2014
22.3.6 Sales by Geography
22.3.7 Business Strategy
22.3.8 Key Developments
22.3.9 SWOT Analysis
22.4 Glide Pharmaceutical Technologies
22.4.1 Key Facts
22.4.2 Business Description
22.4.3 Business Segmentation
22.4.4 Revenue by Business Segmentation
22.4.5 Revenue Comparison 2013 and 2014
22.4.6 Sales by Geography
22.4.7 Business Strategy
22.4.8 Key Developments
22.4.9 SWOT Analysis
22.5 PharmaJet
22.5.1 Key Facts
22.5.2 Business Description
22.5.3 Business Segmentation
22.5.4 Revenue by Business Segmentation
22.5.5 Revenue Comparison 2013 and 2014
22.5.6 Sales by Geography
22.5.7 Business Strategy
22.5.8 Key Developments
22.5.9 SWOT Analysis
22.6 Zogenix
22.6.1 Key Facts
22.6.2 Business Description
22.6.3 Business Segmentation
22.6.4 Revenue by Business Segmentation
22.6.5 Revenue Comparison 2013 and 2014
22.6.6 Sales by Geography
22.6.7 Business Strategy
22.6.8 Key Developments
22.6.9 SWOT Analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Executive Summary of Global Needle-free Drug Delivery Technologies Market 2014-2019
Exhibit 3: NSIs - Facts and Figures
Exhibit 4: Percentage of NSIs at Different Stages of the Injection Process
Exhibit 5: Percentage of Professionals Exposed to NSIs
Exhibit 6: Various Needle-free Drug Delivery Systems
Exhibit 7: Benefits of Needle-free Drug Delivery Devices
Exhibit 8: Disadvantages of Needle-free Drug Delivery Devices
Exhibit 9: Latest Developments by WHO
Exhibit 10: Global Needle-free Drug Delivery Technologies Market 2014-2019 (US$ million)
Exhibit 11: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type
Exhibit 12: Revenue (US$ million) and CAGR Comparison of Global Needle-free Drug Delivery Technologies Market Segments 2014 and 2019
Exhibit 13: Snapshot of Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014-2019
Exhibit 14: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014-2019 (US$ million)
Exhibit 15: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014
Exhibit 16: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014 and 2019 (in percent)
Exhibit 17: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014-2019
Exhibit 18: YoY Growth Rate of Global Needle-free Drug Delivery Technologies Market Segments 2014-2019
Exhibit 19: Components of Needle-free Jet Injector
Exhibit 20: Ideal Characteristics of a Jet Injector
Exhibit 21: Advantages of Jet Injectors
Exhibit 22: Global Jet Injectors Market 2014-2019 (US$ million)
Exhibit 23: Global Transdermal Patches Market Segmentation by Product Type
Exhibit 24: Global Transdermal Patches Market Segmentation by Product Type 2014-2019 (US$ million)
Exhibit 25: Global Transdermal Patches Market Segmentation by Product Type 2014 and 2019
Exhibit 26: Global Transdermal Patches Market Segmentation by Product Type 2014-2019
Exhibit 27: Yoy Growth Rate of Global Transdermal Patches Market Segments 2014-2019
Exhibit 28: Global Transdermal Patches Market 2014-2019 (US$ million)
Exhibit 29: Comparison of Syringe and Microneedle Drug Administration
Exhibit 30: Types of Microneedles
Exhibit 31: Silicon Microneedles
Exhibit 32: Metal Microneedles
Exhibit 33: Advantages of Microneedles
Exhibit 34: Disadvantages of Microneedles
Exhibit 35: Global Microneedles Market 2014-2019 (US$ million)
Exhibit 36: Global Nanopatches Market 2014-2019 (US$ million)
Exhibit 37: Global Needle-free Drug Delivery Technologies Market Segmentation by Application
Exhibit 38: Global Needle-free Drug Delivery Technologies Market Segmentation by Application 2014
Exhibit 39: Revenue (US$ million) and CAGR Comparison of Global Needle-free Drug Delivery Technologies Market Segments by Application 2014 and 2019
Exhibit 40: Global Needle-free Drug Delivery Technologies Market Segmentation by Application 2019
Exhibit 41: Global Needle-free Drug Delivery Technologies Market Segmentation by Application 2014-2019 (US$ million)
Exhibit 42: Global Needle-free Drug Delivery Technologies Market Segmentation by Application 2014-2019
Exhibit 43: Global Insulin Delivery Market 2014-2019 (US$ million)
Exhibit 44: Global Vaccines Market 2014-2019 (US$ million)
Exhibit 45: Global Pediatric Injections Market 2014-2019 (US$ million)
Exhibit 46: Global Needle-free Drug Delivery Technologies Market Segmentation by Geography 2014
Exhibit 47: Buying Criteria of Global Needle-free Drug Delivery Technologies Market 2014
Exhibit 48: Drivers of Global Needle-free Drug Delivery Technologies Market
Exhibit 49: Challenges of Global Needle-free Drug Delivery Technologies Market
Exhibit 50: Bioject: Needle-free Drug Delivery Pipeline Portfolio
Exhibit 51: 3M: Business Segmentation 2014
Exhibit 52: 3M: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 53: 3M: Sales by Geography (in US$ million)
Exhibit 54: Celgene: Business Segmentation by Revenue 2013 and 2014
Exhibit 55: Celgene: Sales by Geography 2014 (Pharmaceuticals Division)
Exhibit 56: Celgene: Sales by Geography 2014 (Diagnostics Division)
Exhibit 57: Bioject: Business Segmentation by Revenue 2014
Exhibit 58: Bioject: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 59: Bioject: Sales by Geography 2014
Exhibit 60: Glide Pharmaceutical Technologies: Business Segmentation
Exhibit 61: Glide Pharmaceutical Technologies: Revenue by Business Segmentation 2014
Exhibit 62: Glide Pharmaceutical Technologies: Revenue by Business Segmentation 2013 and 2014 (US$ million)
Exhibit 63: Glide Pharmaceutical Technologies: Revenue by Geographical Segmentation 2014
Exhibit 64: PharmaJet: Business Segmentation by Revenue 2014
Exhibit 65: PharmaJet: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 66: PharmaJet: Sales by Geography 2014
Exhibit 67: Zogenix: Business Segmentation by Revenue 2014
Exhibit 68: Zogenix: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 69: Zogenix: Sales by Geography 2014
